Messenger RNA-Based Therapeutics and Vaccines: What's beyond COVID-19?

ABSTRACT: With the rapid success in the development of mRNA vaccines against COVID-19 and with a number of mRNA-based drugs ahead in the pipelines, mRNA has catapulted to the forefront of drug research, demonstrating its substantial effectiveness against a broad range of diseases. As the recent global pandemic gradually fades, we cannot stop thinking about what the world has gained: the realization and validation of the power of mRNA in modern medicine. A significant amount of research has now been concentrated on developing mRNA drugs and vaccine platforms against infectious and immune diseases, cancer, and other debilitating diseases and has demonstrated encouraging results. Here, based on the CAS Content Collection, we provide a landscape view of the current state, outline trends in the research

SUBMITTER: Li D 

PROVIDER: S-EPMC10353067 | biostudies-literature | 2023 Jul

REPOSITORIES: biostudies-literature